Carbylan Therapeutics Inc Logo Image

Carbylan Therapeutics Inc

Most Recent Annual Report

2015 Annual Report, 2016 Form 10K

Carbylan Therapeutics Inc

Carbylan Therapeutics Inc has reached its limit for free report views.

Carbylan Therapeutics Inc does not currently have any hardcopy reports on Click the button below to request a report when hardcopies become available.

Archived Annual Reports

  • Carbylan Therapeutics Inc

About Carbylan Therapeutics Inc

Based in Newark, California

Carbylan Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of novel and proprietary combination therapies. Its product candidate is Hydros-TA, which has completed Phase IIb clinical trial designed to provide rapid and sustained relief from pain associated with osteoarthritis. The company was formerly known as Carbylan Biosurgery, Inc. and changed its name to Carbylan Therapeutics, Inc. in March 2014. Carbylan BioSurgery, Inc. was founded in 2004 and is headquartered in Palo Alto, California.

NASDAQ (See More NASDAQ Companies)
Drugs - Generic (See More Drugs - Generic Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol